sq-11725 has been researched along with topiramate in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Antonsson, M; Bengtsson, O; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Jerndal, G; Wan, H; Winiwarter, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
Leira, R; Pascual, J; Rivas, MT | 1 |
Bilbao, A; Foncea, N; Garcia-Monco, JC; Gomez-Beldarrain, M; Ruiz de Velasco, I | 1 |
Artal-Roy, J; García-Gómara, MJ; Gracia-Naya, M; Huerta-Villanueva, M; Latorre-Jiménez, AM; Mauri-Llerda, JA; Ríos-Gómez, C; Sánchez-Valiente, S; Santos-Lasaosa, S | 1 |
Artal-Roy, J; García-Gomara, MJ; Gracia-Naya, M; Latorre-Jiménez, AM; Mauri-Llerda, JA; Ríos-Gómez, C; Sánchez-Valiente, S; Santos-Lasaosa, S | 1 |
2 trial(s) available for sq-11725 and topiramate
Article | Year |
---|---|
Testing the combination beta-blocker plus topiramate in refractory migraine.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Therapy, Combination; Female; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Neuroprotective Agents; Propranolol; Topiramate; Treatment Outcome | 2007 |
Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anticonvulsants; Anxiety; Depression; Female; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Quality of Life; Surveys and Questionnaires; Topiramate | 2007 |
8 other study(ies) available for sq-11725 and topiramate
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
Topics: Animals; Blood-Brain Barrier; Brain; Extracellular Fluid; Humans; Linear Models; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
[Comparative study of the effectiveness of topiramate and nadolol in the preventive treatment of episodic migraine in independent series of patients].
Topics: Adrenergic beta-Antagonists; Adult; Female; Fructose; Humans; Male; Migraine Disorders; Nadolol; Topiramate | 2010 |
[Predisposing factors affecting drop-out rates in preventive treatment in a series of patients with migraine].
Topics: Adrenergic beta-Antagonists; Adult; Anticonvulsants; Female; Flunarizine; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Neuroprotective Agents; Patient Dropouts; Patient Satisfaction; Prospective Studies; Risk Factors; Topiramate; Treatment Outcome; Young Adult | 2011 |